Article
ABCB1 and ERCC1 gene polymorphisms are associated with nephro- and hepatotoxicity to carboplatin/paclitaxel-based chemotherapy in patients with gynecologic cancers.
European journal of clinical pharmacology - 1 Oct 2020
da Costa Junior Luiz Carlos, de Castro Clarissa Lourenço, Freitas-Alves Daniely Regina, Vianna-Jorge Rosane, Santos Paulo Caleb Júnior Lima
Abstract excerpt
BACKGROUND: Paclitaxel/carboplatin combination is the standard chemotherapeutic protocol for gynecologic cancers, but severe toxicities may compromise treatment. There is great inter-individual variability regarding the incidence and severity of toxicities, which may be due to single-nucleotide polymorphisms (SNPs) affecting drug disposition or cellular sensitivity. Here we investigate the impact of selected SNPs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
